Pfizer: Pfizer launches research and development centre in Beijing

BEIJING/WAM US pharmaceutical giant Pfizer's new research and development (R&D) centre officially opened at BioPark in the Beijing Economic-Technological Development Area (BDA). As the company's third R&D centre in China, the new facility aims to enhance its existing drug development network in the country, integrating China into Pfizer's global early-stage clinical trials and all pivotal ...